Inventor · disambiguated record
Alan Wise
Also filed as: FRASER NEIL JAMES · WISE ALAN
11 granted patents·10 pending applications·28 citations·filing 1999–2023
85Inventor score
Files withIOMET PHARMA LTD10DUKE STREET BIO LTD2BARNES ASHLEY A1MERCK SHARP & DOHME1MERCK SHARP & DOHME LLC1
Top patents by PatentIndex Score
21 records- 0186US11130738B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2020·Granted Sep 28, 2021·2 cites·13 claims
- 0285US9931347B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2014·Granted Apr 3, 2018·6 cites·12 claims
- 0384US10287252B2Inhibitors of tryptophan-2,3-dioxygenase or indoleamine-2,3-dioxygenaseIOMET PHARMA LTD·Filed 2015·Granted May 14, 2019·9 cites·6 claims
- 0481US10590086B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2015·Granted Mar 17, 2020·3 cites·10 claims
- 0563US10047074B2Pharmaceutical compoundIOMET PHARMA LTD·Filed 2015·Granted Aug 14, 2018·1 cites·11 claims
- 0660US2025152585A1Pharmaceutical compoundDUKE STREET BIO LTD·Filed 2023·Application pending·0 cites
- 0754US6518399B1ReceptorSMITHKLINE BEECHAM CORP·Filed 1999·Granted Feb 11, 2003·7 cites·3 claims
- 0853US2022396577A1Novel substituted 1,3-8-triazaspiro[4,5] decane-2,4-dione compounds as indoleamine 2,3-dioxygenase (ido) and/or tryptophan 2,3-dioxygenase (tdo) inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 0951US2003082801A1Novel receptorFiled 2002·Application pending·0 cites
- 1051US2024217968A1Pharmaceutical compoundDUKE STREET BIO LTD·Filed 2022·Application pending·0 cites
- 1147US10858319B2Indole derivatives for use in medicineIOMET PHARMA LTD·Filed 2018·Granted Dec 8, 2020·0 cites·7 claims
- 1246US2006223112A1Novel receptorBARNES ASHLEY A·Filed 2005·Application pending·0 cites
- 1345US10155972B2Screening methodIOMET PHARMA LTD·Filed 2014·Granted Dec 18, 2018·0 cites·20 claims
- 1443US11096930B2Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenaseIOMET PHARMA LTD·Filed 2017·Granted Aug 24, 2021·0 cites·14 claims
- 1540US2016120863A1Slc2a transporter inhibitorsIOMET PHARMA LTD·Filed 2014·Application pending·0 cites
- 1640US2003113810A1Novel assayFiled 2001·Application pending·0 cites
- 1738US2003113814A1Identification of modulators of gpr55 activityFiled 2001·Application pending·0 cites
- 1837US10501458B2Substituted bicyclic fused ring compounds as indoleamine-2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Dec 10, 2019·0 cites·9 claims
- 1937US2003157639A1Modified chemokine receptor ccr-3 and assayFiled 2001·Application pending·0 cites
- 2033US2004254224A1MedicamentsFiled 2002·Application pending·0 cites
- 2132US10167257B2Indole derivatives for use in medicineIOMET PHARMA LTD·Filed 2015·Granted Jan 1, 2019·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →